Virtus ETF Advisers’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$203K Hold
3,500
0.09% 236
2025
Q4
$161K Buy
+3,500
New +$157K 0.08% 280
2025
Q1
Sell
-809
Closed -$66.2K 686
2024
Q4
$66.2K Sell
809
-435
-35% -$43.2K 0.03% 410
2024
Q3
$142K Buy
1,244
+21
+2% +$1.89K 0.07% 331
2024
Q2
$92.3K Sell
1,223
-209
-15% -$14.2K 0.05% 349
2024
Q1
$97.8K Sell
1,432
-96
-6% -$6.65K 0.05% 369
2023
Q4
$96K Sell
1,528
-355
-19% -$18.4K 0.06% 376
2023
Q3
$96K Sell
1,883
-192
-9% -$9.47K 0.06% 337
2023
Q2
$104K Sell
2,075
-136
-6% -$6.45K 0.06% 364
2023
Q1
$82.9K Sell
2,211
-853
-28% -$36.2K 0.05% 381
2022
Q4
$147K Sell
3,064
-2,846
-48% -$112K 0.08% 351
2022
Q3
$142K Buy
5,910
+45
+0.8% +$1.14K 0.06% 362
2022
Q2
$128K Buy
+5,865
New +$136K 0.05% 358

Other funds holding PCVX